SBC Medical Announces Share Repurchase Program

SBC Medical Group Holdings ( (SBC) ) just unveiled an update.

On May 15, 2025, SBC Medical Group Holdings announced a share repurchase program, set to begin on May 20, 2025, with a maximum aggregate amount of $5 million, funded by surplus cash and future free cash flow. Additionally, the company is reviewing the acquisition of all shares of Risenet Co., Ltd., which could impact its consolidated financials. In the first quarter of 2025, SBC Medical reported a 14% decrease in total revenues to $47 million, attributed to the discontinuation of its staffing business and divestitures. However, net income rose by 15% year-over-year to $22 million, demonstrating the company’s strategic focus on expanding its franchise model and adapting to market dynamics.

Spark’s Take on SBC Stock

According to Spark, TipRanks’ AI Analyst, SBC is a Neutral.

SBC Medical Group Holdings demonstrates robust financial performance with strong profitability and financial stability, though cash flow management needs improvement. The technical analysis indicates a bearish trend, while valuation metrics are concerning due to the negative P/E ratio. The recent investment in Bitcoin represents a strategic diversification move, enhancing long-term stability.

To see Spark’s full report on SBC stock, click here.

More about SBC Medical Group Holdings

SBC Medical Group Holdings, headquartered in Irvine, California and Tokyo, Japan, is a global provider of management services and products to cosmetic treatment centers. The company focuses on offering comprehensive management services to franchise clinics, including advertising, staff management, booking, and procurement of medical equipment, among other services.

Average Trading Volume: 30,596

Technical Sentiment Signal: Sell

Current Market Cap: $362.6M

Learn more about SBC stock on TipRanks’ Stock Analysis page.